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Azetidines are four-membered nitrogen heterocycles. They are 
of great interest for fundamental research and useful for practical 
applications; for example, 2-azetidinone is the key feature of the 
β-lactam antibiotics.1 Several natural products carry the azetidine 
motif; among them, the α-aminoacid azetidine-2-carboxylic acid, 
a powerful proline antagonist in plant tissue cultures,2 and some 
of its functionalized derivatives, such as the phytosiderophores 
nicotianamine3a-c and mugineic acid,3d-g and the structurally 
related 2”-hydroxynicotianamine, an ACE-inhibitor (Figure 1).3h,i  
Other naturally-occurring azetidines include the vioprolides, 
antifungal and cytotoxic peptolides, exemplified by vioprolide 
A,4a and the polyoxins A, F, H and K, peptide nucleosides with 
antifungal and antiparasitic activity, possibly involved in cell 
wall chitin biosynthesis.4b-e Additional representatives of natural 
azetidines are the cytotoxic and antibacterial penaresidines5 and 
the related penazetidine A, an inhibitor of protein kinase C.6 
Interestingly, natural products such as gelsemoxonine,7a-c the 
insecticidal alkaloid okaramine B7d,e and calydaphninone7f also 
carry fused polysubstituted azetidine moieties. 
Azetidines are also of interest because of their presence in 
synthetic intermediates and bioactive compounds,8 including the 
non-opioid analgesic ABT-594, the thrombin inhibitors exenta 
and melagatran,9a,b and aggrecanase and β-amyloid cleaving 
enzyme-1 inhibitors.9c,d They are also found in certain NMDA 
receptor10a and cholinergic channel modulators,10b antivirals10c 
and inducers of cytokine production.10d Their suitability as 
natural aminoacid surrogates,11a and tools in peptidomimetics11b 
and nucleic acid chemistry,11c-e is also remarkable.  
Ligands featuring the azetidine moiety have been employed in 
various catalytic processes, including reductions,12a,b asymmetric 
Et2Zn,12c-g and Henry additions to aldehydes,12g cycloadditions,13a 
cyclopropanations13b and other C-C bond forming reactions 
(Suzuki, Sonogashira, Michael)13b-e with promising results. In 
addition, C2-symmetric bis(aziridines) have been used as 
bidentate ligands in transition metal catalyzed reactions.14 
Synthetic approaches towards optically active polysubstituted 
azetidines have been recently reviewed.15 These have been 
comparatively less studied than the aziridines, pyrrolidines and 
piperidines, their lower and higher homologous small-ring 
saturated single-nitrogen heterocycles, and several authors have 
pointed out the paucity of short, general and efficient methods for 
the synthesis of enantiopure azetidines.16  
Furthermore, the low number of publications on optically 
active polysubstituted azetidines also reflects the need of new 
enantioselective approaches towards these heterocycles.16b 
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A concise organocatalytic approach towards optically active 1,2,3-trisubstituted azetidines,
including a study of the scope and limitations of the synthetic sequence, is reported. The
synthesis comprises the one-pot L-proline promoted three-component reaction between
substituted benzaldehydes, anilines and enolizable aldehydes, followed by the in situ reduction
of the resulting β-aminoaldehydes to the corresponding γ-aminoalcohols and final
intramolecular cyclization of the latter by way of the intermediate tosylates, formed in situ. 






Marinetti et al.16c conjectured that the reason for the lack of 
progress in the development of the chemistry of optically active 
azetidines could be related to synthetic difficulties associated to 
the formation of the four-membered ring from acyclic 
derivatives; this is a disfavored process compared to the 
analogous construction of slightly larger and even smaller rings.  
Therefore, herein we report the development of the first 
enantioselective organocatalyzed approach to 1,2,3-trisubstituted 
azetidines employing a one-pot synthesis of γ-aminoalcohols 
followed by their microwave-assisted cyclization with TsCl-
Et3N. No protecting groups are employed. The γ-aminoalcohols 
result from a tri-component cross-Mannich synthesis of β-amino 





carboxylic acid Nicotianamine R1=R2= H, R3= NH2
2"-Hydroxynicotianamine R1= H, R2= OH, R3= NH2















Penaresidine A R1= OH, R2= β-Me, R3= H, R4= Me
Penaresidine B R1= OH, R2= H, R3= Me, R4= Me































































































Figure 1. Some relevant azetidine-type natural and pharmaceutical products. 
To that end, 4-nitrobenzaldehyde (1), propanal (4) and 3,4-
dimethoxyaniline (2) were reacted with 20 mol% L-proline as 
chiral organocatalyst (Scheme 1).18 Under these conditions, the 
use of NMP at r.t. met with failure, while adding 4Å MS to a 
mixture of the benzaldehyde and the amine in order to promote 
pre-formation of the Schiff base (3), and reacting the latter at -
20ºC with propanal (4) provided only minor amounts of the 
expected intermediate 5, which proved to be highly unstable to 






















Scheme 1. Reagents and conditions: a) L-proline (20 mol%), NMP, MW 
(70ºC, 1 h); b) R1CH2CHO (4), NMP, -20ºC, 24 h; c) NaBH4, MeOH, Et2O, 
0ºC, 1 h. 1:2: 4= 1.0:1.1:3.0. For the identity of R1-R3, see Table 2. 
 
Therefore, the protocol was modified to include pre-formation 
of the Schiff base and to avoid isolation of the β-aminoaldehyde. 
Schiff base pre-formation in absence of molecular sieves proved 
to be more efficient under microwave irradiation (70ºC, 1 h) than 
under conventional heating. Dropwise addition of 4 (3 equiv.) 
furnished the expected β-aminoaldehyde 5, which was reduced in 
situ with NaBH4 in MeOH, to the corresponding γ-aminoalcohol 
6, which was uneventfully purified (62% overall yield).19  
It was also observed that the reaction solvent played a key role 
in the yield and outcome of the transformation. Anhydrous 
DMSO, gave 45% γ-aminoalcohol, while a 1:1 DMSO/CH2Cl2 
mixture yielded no useful products and a 2:1 DMSO/CH2Cl2 
solvent furnished mainly aldol condensation derivatives. 
Analogously, 50% yield of γ-aminoalcohol was realized in DMF, 
while a 1:1 mixture of DMF and CH2Cl2 gave mainly the imine. 
Therefore, the syntheses of γ-aminoalcohols 6 to explore the 
scope and limitations of the reaction were carried out in NMP. 
The amination of alcohols has been performed employing 
various strategies, which involve converting the carbinol into a 
suitable leaving group (Mitsunobu, Appel-type halogenation, 
formation of sulfonates, carbonates and other esters), followed by 
base-assisted displacement of the latter with the cyclizing 
nitrogen moiety, as the final step.20 
Thus, suitable cyclization conditions were screened (Table 1). 
Initially, formation of the benzoate (PhCOCl-Et3N) followed by 
intramolecular displacement of the latter was attempted;21 
however, this resulted in an incomplete sequence, yielding a 
mixture of products which included the intermediate benzoate 
(runs 3 and 11). On the other hand, activation of the primary 
alcohol as the carbonate (ClCO2Et, Et3N) prior to intramolecular 
displacement gave several inseparable products and low yields of 
the expected products (runs 1 and 4). The report by Couty et al., 
that chloroformates can cleave the azetidine ring, may explain the 
observed low yields.22  





























1 R= NO2, R1= H ClCO2Et 33 92 
2  TsCl 94 92 
3  BzCl -a  
4 R= NO2, R1= OMe ClCO2Et 27 97 
5  TsCl 95 97 
6  ClCO2Et  6b 97 
7  TsCl  51c  
8 R= H, R1= OMe ClCO2Et  16 91 
9  TsCl 69 91 
  
 3
10 R= Cl, R1=OMe TsCl 90 96 
11  BzCl -a  
12  MsCl 55 96 
a Formation of the benzoate was observed; b Formation of the carbamate was 
observed (27%); c Under conventional heating; d Determined by chiral HPLC 
with a Chiralcel OD column, eluting with hexanes:IPA (10:1) at 1 mL/min.  
 
Finally, reaction with TsCl and Et3N under microwave 
irradiation resulted in smooth and clean cyclizations (entries 2, 5, 
9 and 10), which successfully competed with the corresponding 
thermal conditions (entry 7) and with the related MsCl-Et3N 
process (entry 12),23 perhaps because in the latter case, the 
sulfene intermediates generated under the reaction conditions 
may undergo side reactions lowering product yields or 
demanding great excess of the reagent.24 









































% Yield  


























62 57 (97) -207.4 
(c= 1.0) 
















67 90 (96) -218.9  
(c= 1.1) 










Imine -  




















35 69 (92) -168.7  
(c= 1.2) 







15 R2=R3=R5=H,  
R4=NO2 
α-Naphthylamine Imine -  




Imine -  











21 34 (83) -174.3  
(c= 0.3) 




62 94 (93) -223.4  
(c= 1.1) 




56b 36 (97) -196.7 
(c= 0.4) 
a by chiral HPLC with a Chiralcel OD column, eluting with hexanes:IPA 
(10:1) at 1 mL/min; b Reaction with 3-phenylpropanal (R1= Ph in 6 and 7). 
 
With suitable cyclizing conditions, the scope and limitations 
of the protocol were studied with different benzaldehydes and 
anilines.25 It was observed that steric hindrance exerted a major 
effect on the outcome. On the benzaldehyde side, the reaction 
accepted compounds carrying electron withdrawing and electron 
releasing substituents, but the presence substituents ortho to the 
formyl moiety resulted in intermediate imines (3), which failed to 
undergo the Mannich reaction (entries 9, 11 and 12), except with 
the more activated aldehydes (entries 5 and 8), albeit at the 
expense of reduced yield (entry 8); meta-substituted aldehydes 
reacted uneventfully (entries 6 and 10). 
On the other hand, the results of steric effects were more 
evident on the aniline side. The bulky 2-phenylaniline failed to 
react (entries 14 and 17), while reaction with α-naphthylamine 
and 2-methoxyaniline (entries 15 and 16) furnished the 
corresponding Schiff bases, which failed to further undergo the 
Mannich reaction with propanal. Finally, it was observed that the 
synthetic sequence accepts enolizable aldehydes other than 
propanal, such as 3-phenylpropanal (entry 20). 
The configuration of the azetidines was inferred from that of 
the precursor γ-aminoalcohols18 and NOE experiments confirmed 
their relative configuration. The C2 - C3 coupling constants of the 
heterocycles were in the range 7.2-8.5 Hz in their 1H NMR 
spectra and only one diastereomer was always obtained.  
Chemical yields ranged from moderate to good for both main 
stages (total= five steps), the synthesis of the γ-aminoalcohol and 
its cyclization, while enantiomeric excesses (ees) of the resulting 
products were mostly above 90%. A tendency to lower 
enantiomeric excess values was observed when electron releasing 
substituents were present in the benzaldehyde derived moiety 
(entries 8 and 10) of the γ-aminoalcohol and/or the starting 
aniline carried electron withdrawing substituents (entry 18). 
In conclusion, a two-stage organocatalytic enantioselective 
approach to the synthesis of 1,2,3-trisubstituted azetidines, which 
does not require protective groups, was developed; its scope and 
limitations were studied. Overall chemical and optical yields 
were highly satisfactory; however, the one-pot synthesis of the 
intermediate γ-aminoalcohols was influenced by steric and 
electronic factors, sometimes resulting in unsuccessful 
transformations. Due to its simplicity and effectiveness, the 
sequence may find use in synthetic organic chemistry. 
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